pharma news today glp-1 today Can the healthcare system catch up to drug use? GLP-1 Pipeline Update: November 2025

Specialises in: Cultivating a welcoming and comfortable environment, where clients feel valued, respected and at ease, as well as providing expert advice and guidance

has served as a consultant for Kadmon Holdings

When to contact your GP or prescriber: Injection site symptoms persisting beyond 3-4 days Concerns about injection technique or medication administration Difficulty adhering to treatment due to pain or anxiety Questions about managing minor injection site reactions Any unexpected or concerning symptoms following injection Maintaining open communication with your healthcare team ensures optimal treatment outcomes and allows prompt identification and management of any complications

If shedding continues or gets worse, it's worth talking to a health care professional to rule out other causes and explore treatment options

Leflunomide: dermatologic perspective